Sp799
INTRAOPERATIVE PANCREATOSCOPY IS NOT NEEDED TO GUIDE SURGICAL RESECTION OF MAIN DUCT IPMNS
Date
May 20, 2024
Presenter
Tracks
Related Products
EXERCISE STIMULATES ANTITUMORAL IMMUNITY IN PANCREATIC DUCTAL ADENOCARCINOMA
The majority of pancreatic ductal adenocarcinoma (PDAC) patients are metastatic at presentation with limited treatment options and a poor overall 5-year survival of 3%. The liver is the predominant site of distant metastasis in PDAC…
A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
UTILIZATION OF NEOADJUVANT THERAPY IN ELDERLY PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: AN NCDB STUDY
Management of patients with margin negative, T1-T3, N0 (stage IB–IIIA), resected gallbladder cancer (GBC) remains poorly defined. Current guidelines consider observation, chemotherapy (CT), and chemoradiation (CRT) as options…
